Biotech

All Articles

Biogen, UCB file stage 3 lupus succeed after stopping working earlier test

.Biogen and also UCB's bet one's bottom dollar developing in to phase 3 astride a broken research lo...

Aptadir hopes new RNA preventions may reverse complicated cancers

.Italian biotech Aptadir Therapies has actually launched with the commitment that its own pipe of pr...

Wave surfs DMD results to regulatory authorities' doors, sending out stockpile

.Wave Lifestyle Sciences has satisfied its own target in a Duchenne muscle dystrophy (DMD) research,...

Sanofi plucks brand new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma fold, occupyi...

Achilles drops tissue treatment system, prepares for discharges after missing out on 'business feasibility' targets

.Achilles Therapies has actually destroyed its technique. The British biotech is actually stopping w...

Aligos trumpets stage 2 MASH gain, reducing liver excess fat up to 46%

.Aligos Therapeutics is declaring a midstage win in metabolic-dysfunction connected steatohepatitis ...

Basilea ratings $268M BARDA backing for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work establishing brand new antifungals has gotten a significant increase c...

Capricor sells Europe legal rights to late-stage DMD treatment for $35M

.Having presently gathered up the U.S. civil rights to Capricor Therapeutics' late-stage Duchenne mu...

FDA scraps adcomm for Applied's unusual health condition medication

.After dismissing the decision date for Applied Therapeutics' metabolic ailment medication govoresta...

Novo inks $600M NanoVation deal to study hereditary medicines ex-liver

.Novo Nordisk is proceeding its own press in to genetic medicines, accepting to compensate NanoVatio...